|
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 0,2700 GBX | +3,85% |
|
0,00% | -12,90% |
| 07/01 | EnSilica celebra un semestre "solido"; Crescono i ricavi di Aptamer | AN |
| 07/01 | Solvonis Therapeutics plc riceve la Notice of Allowance dall’Ufficio Brevetti e Marchi degli Stati Uniti | CI |
Principali concorrenti
Aggiungi a un elenco 0 selezionato | Variaz. | Variaz. 5g. | Variazione 1 mese | Variazione 3 mesi | Variaz. 1 gen. | Variaz. 1 anno | Variaz. 3 anni | Variaz. 5 anni | Variaz. 10 anni | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3,85% | 0,00% | -9,09% | -10,00% | -12,90% | +38,46% | -97,79% | - | - | 24,19 Mln | |
| +0,16% | -2,45% | -6,68% | -2,60% | -3,94% | -14,44% | -6,00% | -12,11% | +273,00% | 47,17 Mrd | |
| -0,07% | +4,77% | - | - | - | - | - | - | - | 43,15 Mrd | |
| +1,31% | +2,44% | +4,60% | +10,46% | +16,33% | +58,13% | +42,03% | -4,70% | +1.177,77% | 38,6 Mrd | |
| -1,09% | +12,07% | +4,84% | +31,58% | +25,69% | +31,74% | +50,02% | -19,65% | +158,23% | 34,53 Mrd | |
| -5,30% | -21,10% | -24,73% | -13,31% | -19,06% | -12,34% | -20,78% | -0,75% | +221,78% | 32,68 Mrd | |
| +0,05% | +0,34% | - | - | - | - | - | - | - | 20,32 Mrd | |
| -0,79% | -1,21% | -19,10% | +57,32% | +20,50% | +127,49% | +280,12% | +76,79% | - | 18,7 Mrd | |
| -0,06% | +0,21% | - | - | - | - | - | - | - | 16,61 Mrd | |
| -15,90% | -24,16% | -25,03% | -24,29% | -20,58% | +25,97% | +97,75% | +183,73% | - | 14,94 Mrd | |
| +0,33% | -0,35% | -2,66% | +15,72% | +8,08% | +32,24% | -1,17% | -15,73% | +141,42% | 14,13 Mrd | |
| -0,59% | +1,47% | +4,97% | +14,60% | +6,55% | +168,44% | +114,15% | +42,07% | +154,12% | 13,73 Mrd | |
| +0,97% | +0,27% | +10,44% | +13,38% | +5,14% | +85,48% | +89,32% | +45,50% | +1.146,89% | 13,63 Mrd | |
| -3,73% | -5,66% | -41,73% | +104,92% | +27,05% | +25.553,85% | +3.279,35% | - | - | 13,7 Mrd | |
| -6,48% | -19,06% | -20,31% | -9,17% | -20,67% | -25,28% | -38,29% | -28,25% | +116,36% | 11,8 Mrd | |
| -1,67% | -1,57% | - | - | - | - | - | - | - | 10,96 Mrd | |
| +0,59% | -2,11% | +5,78% | +11,40% | +7,91% | +17,38% | -6,93% | -15,35% | +114,65% | 10,46 Mrd | |
| -1,04% | -0,69% | -1,37% | +12,87% | +10,19% | -11,00% | -14,58% | -33,53% | +206,06% | 10,24 Mrd | |
| -2,17% | -4,56% | -15,68% | -21,91% | -5,37% | -18,97% | - | - | - | 10,16 Mrd | |
| +0,09% | +0,47% | - | - | - | - | - | - | - | 9,56 Mrd | |
| Media | -1,54% | -1,87% | -9,05% | +12,73% | +2,99% | +1.737,14% | +269,09% | +18,17% | +371,03% | 19,26 Mrd | |
| Media ponderata per Capi. | -1,43% | -1,09% | -7,95% | +12,68% | +4,63% | +1.260,93% | +204,56% | +10,99% | +420,66% |
- Mercati
- Azioni
- Azione SVNS
- Settore Solvonis Therapeutics plc
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
MarketScreener is also available in this country: United States.
Switch edition
Rimanere sul sito del Paese attuale